Lupus-related mitral valve disease: Embolic coronary occlusion as a unique cause of myocardial infarction

Canadian Journal of Cardiology

Volumn 13, Issue 9, 1997, Pages 859-863

  Giri, Satyendra ^a   Parke, Anne L ^b   Mangion, Judy ^b   Hasson, Jack ^b   Gillam, Linda ^b   Waters, David D ^b  

^a HARTFORD HOSPITAL   (United States)

^b NONE

Author keywords

Mitral valve disease; Systemic lupus erythematosus

Indexed keywords

ADOLESCENT; ARTERY EMBOLISM; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY THROMBOSIS; ENDOCARDITIS; FEMALE; HEART INFARCTION; HUMAN; MITRAL VALVE DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; EMBOLISM; ENDOCARDITIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL INFARCTION;

EID: 0030828795     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Inern Med 1924;33:701-37.
2. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine 1954;33:291-437.
3. Hochberg MC, Dorsch CA, Feinglass EJ, Stevens MB. Survivorship in systemic lupus erythematosus. Arthritis Rheum 1981;24:54-9.
4. Roubenoff R, Hochberg MC. Systemic lupus erythematosus. In: Bellamy N, ed. Prognosis in the Rheumatic Diseases. Lancaster: Kluwer Academic Publishers, 1991:193-4.
5. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971;50:85-95.
6. Grigor R, Edmonds J, Lewkonia R, et al. Systemic lupus erythematosus: a prospective analysis. Ann Rheum Dis 1978;37:121-8.
7. Baehr G, Klemperer P, Shifrin A. A diffuse disease of the peripheral circulation (usually associated with lupus erythematosus and endocarditis). Trans Assoc Am Phys 1935;50:139-55.
8. Gross L. The cardiac lesions in Libman-Sacks disease with a consideration of its relationship to acute diffuse lupus erythematosus. Am J Pathol 1940;16:375-407.
9. Klemperer P, Pollack AD, Baehr G. Pathology of disseminated lupus erythematosus. Arch Pathol 1941;32:569-631.
10. Shahian DM, Labib SB, Schneebaum AB. Etiology and management of chronic valve disease in antiphospholipid antibody syndrome and systemic lupus erythematosus. J Card Surg 1995;10:133-9.
11. Roberts WC, Perioff JK. Mitral valvular disease. A clinicopathological survey of the conditions causing the mitral valve to function abnormally. Ann Intern Med 1972;77:939-75.
12. Bridgen W, Bywaters EGL, Lessof M, Ross IP. The heart in systemic lupus erythematosus. Br Heart J 1960;22:1-16.
13. Griffith GC, Vural IL. Acute and subacute disseminated lupus erythematosus: a correlation of clinical and postmortem findings in eighteen cases. Circulation 1951;3:492-500.
14. Shearn M. The heart in systemic lupus erythematosus. Am Heart J 1959;58:452-66.
15. Dubois E. Lupus Erythematosus. New York: McGraw-Hill Book Co, 1966:162-3.
16. Hejtmancik MR, Wright JC, Quint R. The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1964;68:119-30.
17. Harrison MR, Smith MD, O'Connor WN, DeMaria AN. Post-operative valve ring formation, coronary arteritis, and myocardial infarction in systemic lupus erythematosus. Am Heart J 1986;112:414-7.
18. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Circulation 1997;95:1686-744.
19. Dajee H, Hurley EJ, Szarnick RJ. Cardiac valve replacement in systemic lupus erythcmatosus - A review. J Thorac Cardiovasc Surg 1983;85:718-26.
20. Bulkely BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 1975;58:243-64.
21. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-del-Casrillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1988;319:817-23.
22. Roberts WC, Dangel JC, Bulkely BH. Non-rheumatic valvular cardiac disease: clinicopathologic survey of 27 different conditions causing valvular dysfunction. Cardiovasc Clin 1973;5:333-446.
23. Brennan FJ, Ford SE, Ford PM, Morrin PA, Burggraf GW, Salerno TA. Mitral regurgitation due to lupus endocarditis treated with valve replacement. Can Med Assoc J 1983;129:584-7.
24. Paget SA, Bulkely BH, Grauer LE, Seningen R. Mitral valve disease of systemic lupus erythematosus: a cause of severe congestive heart failure reversed by valve replacement. Am J Med 1975;59:134-9.
25. Bulkely BH, Roberts WC. Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease. Am J Cardiol 1975;35:305-8.
26. Seningen RP, Borer JS, Redwood DR, Bulkely BH, Paget SA. Libman-Sacks endocardoma: diagnosis during life with radiographic, fluoroscopic, and angiographie findings Radiology 1974;113:597-8.
27. Straaton KV, Chatham WW, Reveille JD, Koopman WJ, Smith SH. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med 1988;85:645-50.
28. Rawsthome L, Ptacin MJ, Choi H, Olinger GN, Bamrah VS. Lupus valvulitis necessitating double valve replacement. Arthritis Rheum 1981;24:561-4.
29. Klinkoff AV, Thompson CR, Reid GD, Tomlinson CW. M-mode and two-dimensional echocardiographic abnormalities in systemic lupus erythematosus. JAMA 1985;253:3273-7.
30. Elkayam U, Weiss S, Laniado S. Pericardial effusion and mitral valve involvement in systemic lupus erythematosus: echocardiographic study. Ann Rheum Dis 1977;36:349-53.
31. Nihoyannopoulos P, Gomez PM, Joshi J, et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 1990;82:369-75.